Gonococcal Infection and Antimicrobial Resistance·Original Article
Factors associated with the raising prevalence of gonorrhea in Shenzhen in 2016
Wang Honglin, Cai Yumao, Lan Lina, Wu Xiaobing, Zhang Chunlai, Ye Jianbin, Weng Rongxing, Hong Fuchang, Chen Xiangsheng
Published 2019-08-25
Cite as Inter J Epidemionl Infect Dis, 2019,46(4): 301-305. DOI: 10.3760/cma.j.issn.1673-4149.2019.04.011
Abstract
ObjectiveTo analyze the factors affecting the raising prevalence of gonorrhea in Shenzhen in 2016, so as to provide references for the formulation of relevant prevention and control strategies.
MethodsThe special questionnaires were used to collect relevant data, which included the outpatient quantities, laboratory methods, test numbers and the positive numbers of STD diagnosis in shenzhen in 2015-2016, so as to calculate the raising prevalence of gonorrhea, and conduct the sensitivity analysis.
ResultsThe number of outpatients in the STD-related departments of the 31 medical institutions surveyed in 2016 (5 750 134 cases) increased by 9.97% compared with 2015. In 2016, the prevalence of gonorrhea, laboratory detection rate, and sensitivity of detection methods increased compared with 2015, with growth rates of 16.55%, 42.86%, and 0.10%, respectively. Sensitivity analysis showed that the population prevalence and laboratory detection rate contributed 0.24 and 0.49 to the increasing incidence of gonorrhea, respectively. While the sensitivity of the experimental method, the correct diagnosis rate, and the report rate contributed little to the incidence growth rate of gonorrhea in Shenzhen in 2016.
ConclusionsThe increasing number of gonorrhea cases in Shenzhen in 2016 may be related to the increasing prevalence rate and laboratory detection rate.
Key words:
Gonorrhoea; Factors; Raising prevalence
Contributor Information
Wang Honglin
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Cai Yumao
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Lan Lina
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Wu Xiaobing
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Zhang Chunlai
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Ye Jianbin
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Weng Rongxing
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Hong Fuchang
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, Guangdong, China
Chen Xiangsheng
Institute of Dermatology, Chinese Academy of Medical Sciences; National Center for STD Control, China CDC, Nanjing 210042, China
